Quality & Analytics·8 min read

HPLC and Mass Spectrometry: How Certificates of Analysis Verify Peptide Identity and Purity

A technical guide to interpreting peptide certificates of analysis (COAs), covering reversed-phase HPLC purity methodology, ESI-MS and MALDI-TOF identity confirmation, and what separates research-grade from substandard peptide material.

IAD Research Team·

Why COA Documentation Matters in Peptide Research

Experimental reproducibility in peptide research depends fundamentally on the chemical identity and purity of the test compound. A peptide preparation contaminated with deletion sequences, diastereomers, oxidation products, or residual reagents will produce variable, uninterpretable, or misleading biological data. The certificate of analysis (COA) issued by a third-party analytical laboratory is the primary documentation establishing compound identity, purity, and suitability for research use. Researchers acquiring synthetic peptides from commercial suppliers should critically evaluate COA documentation before committing to experimental protocols. All research described is for scientific, laboratory purposes only. Not for human use.

Reversed-Phase HPLC: Principles and Purity Assessment

Reversed-phase high-performance liquid chromatography (RP-HPLC) separates peptide mixtures based on hydrophobic interactions between analytes and a nonpolar stationary phase (typically C18 octadecylsilyl-bonded silica, 5 µm particle size, 300 Å pore size for peptides). Mobile phases consist of aqueous solvent A (0.1% TFA or 0.1% formic acid in water) and organic solvent B (acetonitrile or methanol, 0.1% TFA/formic acid). A linear gradient from low-B to high-B elutes analytes in order of increasing hydrophobicity.

For peptide purity assessment, detection at λ = 214 nm (amide bond n→π* absorbance) provides near-universal detection of all peptide-containing species. Aromatic-containing peptides (Trp, Tyr, Phe) may also be detected at 254 or 280 nm to confirm amino acid composition. The chromatographic purity is calculated as the percentage area under the curve (AUC%) of the target peak relative to total integrated signal:

Purity (%) = [AUC_target / Σ AUC_all peaks] × 100

Research-grade peptides are expected to achieve ≥95% purity by RP-HPLC; high-specification materials for mechanistic research often require ≥98%. Common impurities observable in the chromatogram include:

  • Deletion sequences: Peptides missing one or more amino acids due to incomplete coupling during SPPS, typically eluting earlier (more hydrophilic) than the full-length target.
  • Diastereomers: Partial racemization at α-carbons (especially His, Cys, Ser) during activation introduces D-amino acid epimers, which may not be baseline-resolved by standard C18 methods — requiring specialized chiral HPLC or capillary electrophoresis for detection.
  • Oxidation products: Met, Cys, and Trp residues are susceptible to oxidation (+16 Da for sulfoxide, +32 Da for sulfone) during synthesis or storage. These are typically resolved from the parent compound on RP-HPLC.
  • Trifluoroacetic acid (TFA) salt vs. acetate salt: TFA from HPLC purification forms an ion pair with cationic peptides; counterion exchange may be performed for applications where TFA is incompatible with assay biology.
  • Residual protecting groups: Incomplete side-chain deprotection leaves Pbf (Arg), tBu (Ser, Thr, Asp, Glu), or Trt (Cys, Asn, Gln, His) groups, adding characteristic mass shifts (+42, +56, +242 Da, respectively).

Column Selection and Method Validation for Peptides

Optimal RP-HPLC method parameters for peptide analysis:

  • Column: C18, 150 mm × 4.6 mm (analytical), 5 µm, 300 Å pore (large-pore silica improves mass transfer for peptides >3 kDa)
  • Flow rate: 1.0 mL/min; temperature: 40°C (improves peak shape by reducing secondary structure equilibration broadening)
  • Gradient: 5–65% B over 20 minutes is a common starting condition, adjusted based on peptide hydrophobicity
  • Injection volume: 10–50 µL at 0.1–1 mg/mL concentration (optimized to avoid detector saturation)
  • System suitability: Plate count N > 5,000; peak asymmetry factor 0.8–1.5; retention time reproducibility < 0.5% RSD

Electrospray Ionization Mass Spectrometry (ESI-MS)

ESI-MS is the primary identity confirmation technique for synthetic peptides. In positive-mode ESI, peptides are ionized by protonation of basic residues (Arg, Lys, His) and the N-terminus, producing multiply charged [M+nH]ⁿ⁺ ions. The observed m/z for each charge state: m/z = (M + n × 1.008) / n, where M is monoisotopic or average molecular weight and n is charge state (equal to number of ionizable basic sites + 1 for most peptides).

Deconvolution software (MaxEnt, or manual calculation) reconstructs the molecular weight from the m/z envelope. A COA confirming peptide identity should report:

  • Theoretical monoisotopic MW (calculated from sequence by summing residue masses + H₂O for linear peptide)
  • Observed [M+H]⁺ or most abundant charge state m/z
  • Mass accuracy: ±0.1 Da for low-resolution instruments (single quadrupole); ±5 ppm for high-resolution instruments (TOF, Orbitrap)

For peptides with MW >5,000 Da, ESI charge state distributions become complex; MALDI-TOF (below) may provide cleaner spectra. For disulfide-containing peptides, MS under reducing conditions (DTT or TCEP) vs. non-reducing conditions distinguishes intramolecular from intermolecular disulfide forms.

MALDI-TOF Mass Spectrometry

Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry uses a UV-absorbing matrix (α-cyano-4-hydroxycinnamic acid/CHCA for small peptides <5 kDa; 2,5-dihydroxybenzoic acid/DHB or sinapinic acid for larger peptides/proteins) to co-crystallize with the analyte on a target plate. Pulsed UV laser (337 nm N₂ or 355 nm Nd:YAG) ablates the matrix, transferring energy and protons to the co-crystallized analyte, generating predominantly singly charged [M+H]⁺ ions. TOF analysis separates ions by m/z based on flight time to the detector (reflectron mode for improved resolution).

Advantages of MALDI-TOF for peptide COA: simple spectrum (predominantly [M+H]⁺ and [M+Na]⁺, [M+K]⁺ adducts), tolerance for salt contamination vs. ESI, and rapid high-throughput acquisition. Limitations include lower mass accuracy (~10–100 ppm for standard linear mode) compared to high-resolution ESI-MS, and matrix suppression effects that can obscure minor impurity peaks. For definitive impurity characterization, LC-MS/MS (tandem MS fragmentation) provides sequence-level identification of deletion sequences or modified variants.

Additional COA Parameters

Amino Acid Analysis (AAA)

Acid hydrolysis of the peptide (6M HCl, 110°C, 24h) followed by derivatization (OPA, PITC, FMOC) and RP-HPLC of amino acid derivatives quantitatively confirms the molar ratio of each amino acid residue, providing an orthogonal identity check independent of MS. AAA also permits accurate peptide quantification by weight (correcting for water content and counterion mass).

Karl Fischer Titration — Water Content

Lyophilized peptides typically contain 5–15% bound water by weight. Karl Fischer volumetric or coulometric titration measures residual water content precisely. This value is critical for accurate molarity calculations in research solution preparation: a peptide reported as 98% pure by HPLC but containing 12% water by KF would require correction of the actual peptide mass per vial.

Endotoxin Testing (LAL Assay)

For research applications involving cell culture or in vivo rodent models, endotoxin contamination from bacterial lipopolysaccharide (LPS) is a major confounding variable given LPS's potent TLR4-activating properties at pg/mL concentrations. The Limulus Amebocyte Lysate (LAL) kinetic turbidimetric assay quantifies endotoxin in Endotoxin Units (EU)/mg or EU/mL. Research-grade peptides for cell-based assays typically require <1 EU/mg; in vivo rodent studies may require <5 EU/kg body weight.

Interpreting a Peptide COA: Checklist

  • ✓ Sequence confirmed (correct amino acid composition by AAA or sequence tag by MS/MS)
  • ✓ MW confirmed within instrument tolerance (ESI-MS or MALDI-TOF)
  • ✓ HPLC purity ≥95% (≥98% preferred for mechanistic research)
  • ✓ Single predominant HPLC peak (no co-eluting major impurity peaks)
  • ✓ Water content reported (KF or TGA)
  • ✓ Batch/lot number traceable to synthesis and QC records
  • ✓ Storage conditions stated (typically −20°C under inert atmosphere)
  • ✓ Issuing laboratory identified (ISO 17025-accredited preferred)

Iron All Day provides full COA documentation for all research peptides, including HPLC chromatograms and mass spectra. Browse our full product catalog.

Disclaimer: For research purposes only. Not for human consumption. All products are sold strictly for laboratory use. These statements have not been evaluated by the FDA.

← Back to Research Blog